Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leila Takahashi‐Ruiz
Observed name:
Leila Takahashi-Ruiz
Institution:
The University of Texas at San Antonio Health Science Center
Observed institutions:
The University of Texas at San Antonio Health Science Center,
Virginia Commonwealth University,
Mays Cancer Center at UT Health San Antonio
ORCID:
0000-0003-1814-6465
Observed ORCID:
0000-0003-1814-6465
OpenAlex ID:
A5020172955
Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA
2021
·
Charles S. Fermaintt
, Leila Takahashi-Ruiz
, et al.
·
Molecular Pharmacology
·
35
PDF
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
2022
·
Leila Takahashi-Ruiz
, Charles S. Fermaintt
, et al.
·
Cancers
·
31
PDF
Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
2021
·
Charles S. Fermaintt
, Thilini Peramuna
, et al.
·
Cancers
·
18
PDF
B cell ADAM17 controls T cell independent humoral immune responses through regulation of TACI and CD138
2019
·
Joseph C. Lownik
, Jessica L. Wimberly
, et al.
·
Biochemical and Biophysical Research Communications
·
10
In Vivo Evaluation of (−)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site
2022
·
Leila Takahashi-Ruiz
, Joseph D. Morris
, et al.
·
Molecules
·
8
PDF
Re-evaluation of the Fijianolide/Laulimalide Chemotype Suggests an Alternate Mechanism of Action for C-15/C-20 Analogs
2022
·
Joseph D. Morris
, Leila Takahashi-Ruiz
, et al.
·
ACS Omega
·
6
Abstract 5259: Mechanistic evaluations of the immunological and cell biological effects that distinguish eribulin from other microtubule-targeted chemotherapeutics
2024
·
Zaineb Hassouneh
, Nancy Wilkinson
, et al.
·
Cancer Research
·
1
Abstract 6397: Eribulin acts as an immune adjuvant to enhance the antitumor efficacy of STING agonists in triple-negative breast cancer models
2023
·
Leila Takahashi-Ruiz
, Charles S. Fermaintt
, et al.
·
Cancer Research
429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
2023
·
Leila Takahashi-Ruiz
, Charles S. Fermaintt
, et al.
·
Journal of Clinical and Translational Science
PDF
Abstract P4-07-19: Eribulin enhances STING-dependent induction of type I interferons in immune and triple-negative breast cancer cells
2023
·
Leila Takahashi-Ruiz
, Charles Fermaintt
, et al.
·
Cancer Research
Eribulin Enhances Interferon Production by STING Agonists in Models of Triple‐Negative Breast Cancer
2022
·
Leila Takahashi‐Ruiz
, Charles S. Fermaintt
, et al.
·
The FASEB Journal
Abstract PS17-18: Eribulin-mediated release of mitochondrial DNA activates the cGAS-STING innate immune signaling pathway
2021
·
Charles Steven Fermaintt
, Leila Takahashi-Ruiz
, et al.
·
Cancer Research
Show more works
View as search
Works count:
12
Citation count:
109
H-index:
6
I10-index:
4
Year
Topic
Type